Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures. - Wikidata - wikimedia - TriplyDB

Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.

Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.

http://www.wikidata.org/entity/Q33391484

about

Bivalirudin as a bridge for anticoagulation in high risk neurosurgical patients with active DVT or high risk of thrombosis.Plasma exchange on venovenous extracorporeal membrane oxygenation with bivalirudin anticoagulation.Off-label use of drugs and devices in the neuroendovascular suite.

P2860

Q33406950-6E1444A7-43C8-4AF1-9397-E51EB990E08C Q33419536-AD186309-1A47-4244-A329-CDEB9E988D3C Q38091856-02FBFF2B-E1CF-4650-962F-EBBEBF847AE7

P2860

Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.

http://www.wikidata.org/entity/Q33391484

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Safety and tolerability of hig ...... neuroendovascular procedures.

@ast

Safety and tolerability of hig ...... neuroendovascular procedures.

@en

type

label

Safety and tolerability of hig ...... neuroendovascular procedures.

@ast

Safety and tolerability of hig ...... neuroendovascular procedures.

@en

prefLabel

Safety and tolerability of hig ...... neuroendovascular procedures.

@ast

Safety and tolerability of hig ...... neuroendovascular procedures.

@en

P1433

Q33391484-EFDC86C6-7492-46BA-AA6C-CCC72E83B636

P1476

Q33391484-CBDBB57C-A088-406C-B3AE-BA2EE01F5ACF

P2093

Q33391484-5D8D0BDF-5C44-4977-AD4B-E96C24BE4729

Q33391484-5E70CAC0-C9FA-4426-ADB0-753AFED55305

Q33391484-69BFCE45-9F86-4A51-89CD-0E33C6CB970B

Q33391484-AC7E20CC-1B3B-4B4D-A101-5DC661B3E596

Q33391484-C751EB93-AAAE-47B5-8016-01C65AF10794

Q33391484-D842293D-3DB6-480F-9F0E-D6C376E92C46

P2860

Q33391484-0F619D7F-B93E-45EE-85BE-8F02F4C19EFC

Q33391484-30A719D4-721C-42F9-84BF-3410BA4D19AD

Q33391484-4D26A3B2-93CC-4CD7-8E4E-E09727070F1D

Q33391484-625DA44A-208F-4C8C-A17D-99D314E4368D

Q33391484-7C193214-A18B-4E39-8504-35F7C4AEA806

Q33391484-942DB9CB-28DC-4B4A-ABE1-C1DF8D2BD180

Q33391484-95EC8824-6EB9-4C3E-A176-C3EB7367A8FD

Q33391484-B0952F60-FA20-404F-9482-383BD0AB1904

Q33391484-B33AB097-890F-4280-AA5E-37719717FE5B

Q33391484-C6BB6309-9666-4566-90C2-93DA0EEC7173

P2888

Q33391484-A71B5A18-46EB-4B86-A04E-E2A42E8E06B2

P304

Q33391484-C7BD9DA1-F1A4-4AC6-BD65-69985609B078

P31

Q33391484-88239F19-124A-47CC-AF90-36EAF87993B6

P356

Q33391484-72BB4137-F7A4-489D-8B09-0376C8D1F1EB

P433

Q33391484-ABAE3507-2470-4C68-BB32-EBA117347BDB

P478

Q33391484-AB304D90-C184-433E-AD79-20CB492C59DB

P577

Q33391484-0DF0532D-4D9D-4946-90C1-B1DF5A7E2746

P6179

Q33391484-FA9718E5-9096-495C-8830-D280AB62B669

P698

Q33391484-BB721A3E-7250-4D56-85E4-C3A07E25EDBC

P921

Q33391484-C62EC139-0CB0-4503-8917-DBB347FEA4E0

P356

S12028-010-9421-7

P1433

Neurocritical Care

P1476

Safety and tolerability of hig ...... neuroendovascular procedures.

@en

P2093

Adnan I Qureshi

http://www.w3.org/2001/XMLSchema#string

Alexandros L Georgiadis

http://www.w3.org/2001/XMLSchema#string

Ameer E Hassan

http://www.w3.org/2001/XMLSchema#string

Gabriela Vazquez

http://www.w3.org/2001/XMLSchema#string

M Fareed K Suri

http://www.w3.org/2001/XMLSchema#string

Muhammad Zeeshan Memon

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Bivalirudin during primary PCI in acute myocardial infarction

Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations.

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.

Routine bivalirudin use in percutaneous carotid interventions.

P2888

s12028-010-9421-7

P304

96-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12028-010-9421-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044341782

http://www.w3.org/2001/XMLSchema#string

P698

20721698

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation